Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...

Here are the Thanksgiving foods most likely to produce gas in you, which in turn could make you more flatulent. All the more ...

A predatory gang member who declared "this is what white girls are for" during a vicious sexual assault has received an additional three-year prison sentence for rape. Sageer Hussain was among four ...

Teenagers Scott and Mary are on their way to a Halloween party when their car breaks down, and they encounter a creepy castle where the depraved Dr. Frankenstein seeks to put Scott's brain in his ...